Cargando…
Persistence of COVID-19 Symptoms after Recovery in Mexican Population
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765113/ https://www.ncbi.nlm.nih.gov/pubmed/33327641 http://dx.doi.org/10.3390/ijerph17249367 |
_version_ | 1783628415327272960 |
---|---|
author | Galván-Tejada, Carlos E. Herrera-García, Cintya Fabiola Godina-González, Susana Villagrana-Bañuelos, Karen E. Amaro, Juan Daniel De Luna Herrera-García, Karla Rodríguez-Quiñones, Carolina Zanella-Calzada, Laura A. Ramírez-Barranco, Julio de Avila, Jocelyn L. Ruiz Reyes-Escobedo, Fuensanta Celaya-Padilla, José M. Galván-Tejada, Jorge I. Gamboa-Rosales, Hamurabi Martínez-Acuña, Mónica Cervantes-Villagrana, Alberto Rivas-Santiago, Bruno Gonzalez-Curiel, Irma E. |
author_facet | Galván-Tejada, Carlos E. Herrera-García, Cintya Fabiola Godina-González, Susana Villagrana-Bañuelos, Karen E. Amaro, Juan Daniel De Luna Herrera-García, Karla Rodríguez-Quiñones, Carolina Zanella-Calzada, Laura A. Ramírez-Barranco, Julio de Avila, Jocelyn L. Ruiz Reyes-Escobedo, Fuensanta Celaya-Padilla, José M. Galván-Tejada, Jorge I. Gamboa-Rosales, Hamurabi Martínez-Acuña, Mónica Cervantes-Villagrana, Alberto Rivas-Santiago, Bruno Gonzalez-Curiel, Irma E. |
author_sort | Galván-Tejada, Carlos E. |
collection | PubMed |
description | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19. |
format | Online Article Text |
id | pubmed-7765113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77651132020-12-27 Persistence of COVID-19 Symptoms after Recovery in Mexican Population Galván-Tejada, Carlos E. Herrera-García, Cintya Fabiola Godina-González, Susana Villagrana-Bañuelos, Karen E. Amaro, Juan Daniel De Luna Herrera-García, Karla Rodríguez-Quiñones, Carolina Zanella-Calzada, Laura A. Ramírez-Barranco, Julio de Avila, Jocelyn L. Ruiz Reyes-Escobedo, Fuensanta Celaya-Padilla, José M. Galván-Tejada, Jorge I. Gamboa-Rosales, Hamurabi Martínez-Acuña, Mónica Cervantes-Villagrana, Alberto Rivas-Santiago, Bruno Gonzalez-Curiel, Irma E. Int J Environ Res Public Health Article The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19. MDPI 2020-12-14 2020-12 /pmc/articles/PMC7765113/ /pubmed/33327641 http://dx.doi.org/10.3390/ijerph17249367 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Galván-Tejada, Carlos E. Herrera-García, Cintya Fabiola Godina-González, Susana Villagrana-Bañuelos, Karen E. Amaro, Juan Daniel De Luna Herrera-García, Karla Rodríguez-Quiñones, Carolina Zanella-Calzada, Laura A. Ramírez-Barranco, Julio de Avila, Jocelyn L. Ruiz Reyes-Escobedo, Fuensanta Celaya-Padilla, José M. Galván-Tejada, Jorge I. Gamboa-Rosales, Hamurabi Martínez-Acuña, Mónica Cervantes-Villagrana, Alberto Rivas-Santiago, Bruno Gonzalez-Curiel, Irma E. Persistence of COVID-19 Symptoms after Recovery in Mexican Population |
title | Persistence of COVID-19 Symptoms after Recovery in Mexican Population |
title_full | Persistence of COVID-19 Symptoms after Recovery in Mexican Population |
title_fullStr | Persistence of COVID-19 Symptoms after Recovery in Mexican Population |
title_full_unstemmed | Persistence of COVID-19 Symptoms after Recovery in Mexican Population |
title_short | Persistence of COVID-19 Symptoms after Recovery in Mexican Population |
title_sort | persistence of covid-19 symptoms after recovery in mexican population |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765113/ https://www.ncbi.nlm.nih.gov/pubmed/33327641 http://dx.doi.org/10.3390/ijerph17249367 |
work_keys_str_mv | AT galvantejadacarlose persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT herreragarciacintyafabiola persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT godinagonzalezsusana persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT villagranabanueloskarene persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT amarojuandanieldeluna persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT herreragarciakarla persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT rodriguezquinonescarolina persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT zanellacalzadalauraa persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT ramirezbarrancojulio persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT deavilajocelynlruiz persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT reyesescobedofuensanta persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT celayapadillajosem persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT galvantejadajorgei persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT gamboarosaleshamurabi persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT martinezacunamonica persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT cervantesvillagranaalberto persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT rivassantiagobruno persistenceofcovid19symptomsafterrecoveryinmexicanpopulation AT gonzalezcurielirmae persistenceofcovid19symptomsafterrecoveryinmexicanpopulation |